Phage display of combinatorial antibody libraries
C Rader, CF Barbas III - Current opinion in biotechnology, 1997 - Elsevier
The selection of antibodies from combinatorial libraries displayed on the surface of
filamentous phage has become an important methodology for the generation of reagent …
filamentous phage has become an important methodology for the generation of reagent …
Antibody discovery: sourcing of monoclonal antibody variable domains
WR Strohl - Current drug discovery technologies, 2014 - ingentaconnect.com
Historically, antibody variable domains for therapeutic antibodies have been sourced
primarily from the mouse IgG repertoire, and typically either chimerized or humanized. More …
primarily from the mouse IgG repertoire, and typically either chimerized or humanized. More …
[图书][B] Phage display in biotechnology and drug discovery
The book provides a comprehensive view of the impact and promise of phage display in
drug discovery and biotechnology. Building on the success of its previous edition, the book …
drug discovery and biotechnology. Building on the success of its previous edition, the book …
Characterization of epitope-specific anti-respiratory syncytial virus (anti-RSV) antibody responses after natural infection and after vaccination with formalin-inactivated …
I Widjaja, O Wicht, W Luytjes, K Leenhouts… - Journal of …, 2016 - Am Soc Microbiol
Antibodies against the fusion (F) protein of respiratory syncytial virus (RSV) play an
important role in the protective immune response to this important respiratory virus. Little is …
important role in the protective immune response to this important respiratory virus. Little is …
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen
F Sesterhenn, M Galloux, SS Vollers, L Csepregi… - PLoS …, 2019 - journals.plos.org
Throughout the last several decades, vaccination has been key to prevent and eradicate
infectious diseases. However, many pathogens (eg, respiratory syncytial virus [RSV] …
infectious diseases. However, many pathogens (eg, respiratory syncytial virus [RSV] …
[图书][B] Applications and engineering of monoclonal antibodies
DJ King - 1998 - taylorfrancis.com
A valuable resource for researchers and workers in the fields of both pharmaceuticals and
biotechnology as well as undergraduates in biochemistry, applied biology, biomedical …
biotechnology as well as undergraduates in biochemistry, applied biology, biomedical …
Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous …
S Herfst, M de Graaf, EJA Schrauwen… - Journal of general …, 2007 - microbiologyresearch.org
Human metapneumovirus (hMPV), a newly discovered paramyxovirus, is associated with
acute respiratory-tract illness, primarily in young children, individuals with underlying …
acute respiratory-tract illness, primarily in young children, individuals with underlying …
PCPP-adjuvanted respiratory syncytial virus (RSV) sF subunit vaccine: self-assembled supramolecular complexes enable enhanced immunogenicity and protection
PCPP, a well-defined polyphosphazene macromolecule, has been studied as an
immunoadjuvant for a soluble form of the postfusion glycoprotein of respiratory syncytial …
immunoadjuvant for a soluble form of the postfusion glycoprotein of respiratory syncytial …
Creating and engineering human antibodies for immunotherapy
H de Haard, P Henderikx, HR Hoogenboom - Advanced drug delivery …, 1998 - Elsevier
Targeting in immunotherapy has traditionally been achieved by using monoclonal rodent
antibodies. Despite gene-engineering, there are many problems and limitations associated …
antibodies. Despite gene-engineering, there are many problems and limitations associated …
A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus
AR Hunt, S Frederickson, C Hinkel… - Journal of general …, 2006 - microbiologyresearch.org
A humanized monoclonal antibody (mAb) has been developed and its potential to protect
from or cure a Venezuelan equine encephalomyelitis virus (VEEV) infection was evaluated …
from or cure a Venezuelan equine encephalomyelitis virus (VEEV) infection was evaluated …